Skip to content
10-K

Annual Report

NovoCure Ltd NVCR

0001645113-26-000017

← back to feed
Filed
Feb 26, 2026 12:00 AM ET
Period of report
Restated figures. One or more values in this filing restate previously reported amounts.

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding FY 2025 · Feb 20, 2026 113.79M sh
Shares Diluted FY 2025 · Dec 31, 2025 111.47M sh
Shares Diluted FY 2025 · Dec 31, 2024 107.83M sh
Shares Diluted FY 2025 · Dec 31, 2023 106.39M sh
Capex FY 2025 · Dec 31, 2025 $26.65M
Capex FY 2025 · Dec 31, 2024 $42.86M
Capex FY 2025 · Dec 31, 2023 $27.09M
Operating Cash Flow FY 2025 · Dec 31, 2025 −$49.03M
Operating Cash Flow FY 2025 · Dec 31, 2024 −$26.37M
Operating Cash Flow FY 2025 · Dec 31, 2023 −$73.34M
Long Term Debt FY 2025 · Dec 31, 2025 $195.05M
Long Term Debt FY 2025 · Dec 31, 2024 $97.3M
Cash And Equivalents FY 2025 · Dec 31, 2025 $93.55M
Cash And Equivalents FY 2025 · Dec 31, 2024 $163.77M
Cash And Equivalents FY 2025 · Dec 31, 2023 $240.82M
Stockholders Equity FY 2025 · Dec 31, 2025 $340.47M
Stockholders Equity FY 2025 · Dec 31, 2024 $360.18M
Stockholders Equity FY 2025 · Dec 31, 2023 $362.5M
Stockholders Equity FY 2025 · Dec 31, 2022 $441.17M
Current Liabilities FY 2025 · Dec 31, 2025 $223.23M
Current Liabilities restated FY 2025 · Dec 31, 2024 $756.39M
Total Liabilities FY 2025 · Dec 31, 2025 $463.86M
Total Liabilities FY 2025 · Dec 31, 2024 $880.61M
Current Assets FY 2025 · Dec 31, 2025 $646.73M
Current Assets FY 2025 · Dec 31, 2024 $1.11B
Total Assets FY 2025 · Dec 31, 2025 $804.33M
Total Assets FY 2025 · Dec 31, 2024 $1.24B
Eps Diluted FY 2025 · Dec 31, 2025 −$1.22
Eps Diluted FY 2025 · Dec 31, 2024 −$1.56
Eps Diluted FY 2025 · Dec 31, 2023 −$1.95
Eps Basic FY 2025 · Dec 31, 2025 −$1.22
Eps Basic FY 2025 · Dec 31, 2024 −$1.56
Eps Basic FY 2025 · Dec 31, 2023 −$1.95
Sga Expense FY 2025 · Dec 31, 2025 $177.67M
Sga Expense FY 2025 · Dec 31, 2024 $189.83M
Sga Expense FY 2025 · Dec 31, 2023 $164.06M
Rd Expense FY 2025 · Dec 31, 2025 $224.54M
Rd Expense FY 2025 · Dec 31, 2024 $209.65M
Rd Expense FY 2025 · Dec 31, 2023 $223.06M
Net Income FY 2025 · Dec 31, 2025 −$136.23M
Net Income FY 2025 · Dec 31, 2024 −$168.63M
Net Income FY 2025 · Dec 31, 2023 −$207.04M
Operating Income FY 2025 · Dec 31, 2025 −$153.8M
Operating Income FY 2025 · Dec 31, 2024 −$170.5M
Operating Income FY 2025 · Dec 31, 2023 −$232.87M
Gross Profit FY 2025 · Dec 31, 2025 $488.47M
Gross Profit FY 2025 · Dec 31, 2024 $468.04M
Gross Profit FY 2025 · Dec 31, 2023 $381.06M
Cost Of Revenue FY 2025 · Dec 31, 2025 $166.88M
Cost Of Revenue FY 2025 · Dec 31, 2024 $137.18M
Cost Of Revenue FY 2025 · Dec 31, 2023 $128.28M
Revenue FY 2025 · Dec 31, 2025 $655.35M
Revenue FY 2025 · Dec 31, 2024 $605.22M
Revenue FY 2025 · Dec 31, 2023 $509.34M